How killer T cells fight Chlamydia infection
Cytotoxic T Cell Mediated Immunity to Chlamydia
This project looks at how CD8 'killer' T cells respond to Chlamydia trachomatis so future vaccines or treatments can stop repeat infections and reproductive damage.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard Medical School NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11415248 on NIH RePORTER |
What this research studies
From my point of view, the researchers are using lab tools and animal experiments to see why CD8 T cells protect at first but fail to form strong memory. They transfer Chlamydia-specific CD8 cells into mice and study how those cells act during infection and on re-exposure. The team is also testing vaccine formulations and approaches to overcome the block on long-term CD8 memory. What they learn could point to new vaccine designs that teach the immune system to remember and clear Chlamydia better.
Who could benefit from this research
Good fit: People who have had or are at high risk for genital Chlamydia trachomatis infection, especially those with repeat infections, would be most relevant to this work.
Not a fit: People with unrelated infections or those needing an immediate cure should not expect direct or immediate benefit from this basic and preclinical research.
Why it matters
Potential benefit: If successful, the work could lead to vaccines or immune-based therapies that prevent repeat Chlamydia infections and reduce long-term reproductive harm.
How similar studies have performed: Previous animal work shows transferred CD8 T cells can protect mice from Chlamydia, but reliably inducing lasting CD8 memory after natural infection remains unproven.
Where this research is happening
Boston, United States
- Harvard Medical School — Boston, United States (Active)
Researchers
- Principal investigator: Starnbach, Michael N — Harvard Medical School
- Study coordinator: Starnbach, Michael N
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.